Skip to content
Screener

CONMED CNMD Q1 2026 earnings

Reported April 29, 2026 · After market close

Revenue$317.0MBeat by $6.4M
EPS$0.89Beat by $0.07
Revenue estimate$310.6M
EPS estimate$0.82

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$336.3M
EPS estimate$1.00

Financials

Q1 2026

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$1.09B-41.6%
Enterprise value$1.92B-29.6%
P/E19.9×+4.2×
P/S0.8×-0.6×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Segments

By geography

See full
Europe, Middle East & Africa$69.1M+8.6%
Asia Pacific$42.0M-4.0%
Americas (excluding the United States)$32.9M+9.3%

By product

See full
General Surgery$169.4M-7.4%
Orthopedic Surgery$147.7M+6.8%

FAQ

When did CONMED report Q1 2026 earnings?
CONMED (CNMD) reported Q1 2026 earnings on April 29, 2026 after market close.
What were CONMED's Q1 2026 revenue and EPS?
CONMED reported revenue of $317.0M and eps of $0.89 for Q1 2026.
Did CONMED beat estimates in Q1 2026?
Revenue beat the consensus estimate of $310.6M by $6.4M. EPS beat the consensus estimate of $0.82 by $0.07.
How did CONMED's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.3% from $321.3M a year earlier and eps declined 6.3% from $0.95.
Where can I find CONMED's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000816956-26-000051) and the 10-Q periodic report (0000816956-26-000053) directly on SEC EDGAR. The filing index links above go to sec.gov.